Tarpon Cellars Uses Wine Sales to Help CF Foundation
The funds will help support research and treatment development for cystic fibrosis (CF), an inheritable progressive disorder that affects more than 70,000 individuals globally, including some 30,000 U.S. residents.
Since its 2017 founding in California’s Napa Valley, Tarpon has donated more than $2,000 to CFF.
“As an entrepreneur, I feel that I have a responsibility to give back,”Jeremy Carter, Tarpon Cellars founder and winemaker, said in a press release.
“Wine can be a hedonistic industry but I wanted our customers to feel good about buying our wines by knowing they are contributing to an incredible organization that is making real progress,” Carter added.
Grayton’s Guardians is led by JB and Melissa Pinkston, whose young son Grayton was diagnosed with CF in 2015. It was established by Pinkston family friends, including Carter, who even before the Tarpon partnership supported CFF through events and fundraisers.
“The ongoing support from Tarpon Cellars not only impacts the future for my son, but also the tens of thousands of people who are affected by this disease across the country,” Melissa Pinkston said. “People can feel good about their purchase every time they enjoy a bottle of Tarpon Cellars wine.”
“On behalf of Grayton, our family, and everyone who works so hard to support Grayton’s Guardians and the mission of the CF Foundation, we’d like to thank Tarpon Cellars for their generosity and support in helping Grayton and others with CF add more tomorrows,” the Pinkstons said in a statement on Tarpon’s website.
A producer of single-vineyard, limited-edition wines with grapes from nearby Shifflett Ranch & Vineyard, Tarpon Cellars aims to bring people together through philanthropy, events, and music. The bottles range in price between $30-$50. Please visit this website for more information.
CFF, including the Georgia chapter, invests in research and drug development, promotes personalized treatment, and works to ensure access to high-quality care in order to give CF patients a chance to lead full, productive lives. The overarching goal is a disease cure.